Conley Chee Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

Conley Chee is President & CEO of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 122,504 shares of SYRS, which is worth approximately $240,107. The most recent transaction as insider was on Sep 11, 2024, when has been sold 50,000 shares (Common Stock) at a price of $1.71 per share, resulting in proceeds of $85,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K

444.37% 3M change

9028.46% 12M change

Total Value Held $240,107

Conley Chee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 11 2024	BUY Open market or private purchase	$85,500 $1.71 p/Share	50,000 Added 28.98%	122,504 Common Stock
Sep 10 2024	BUY Open market or private purchase	$75,500 $1.51 p/Share	50,000 Added 40.81%	72,504 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$17,920 $5.12 p/Share	3,500 Reduced 13.46%	22,504 Common Stock
Mar 31 2024	BUY Exercise of conversion of derivative security	-	13,666 Added 34.45%	26,004 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$13,328 $2.22 p/Share	6,004 Reduced 32.73%	12,338 Common Stock
Oct 31 2023	BUY Exercise of conversion of derivative security	-	17,000 Added 48.1%	18,342 Common Stock
Apr 03 2023	SELL Payment of exercise price or tax liability	$1,697 $2.58 p/Share	658 Reduced 32.9%	1,342 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	2,000 Added 50.0%	2,000 Common Stock

Conley Chee

President & CEO

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Value

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Syros Pharmaceuticals, Inc.

Track Activities on SYRS

Account